Home
>
National Drug Code (NDC)
>
Allopurinol
Allopurinol - 57451-5026-2 - (Allopurinol)
Drug Information of Allopurinol
| Product NDC: | 57451-5026 |
| Proprietary Name: | Allopurinol |
| Non Proprietary Name: | Allopurinol |
| Active Ingredient(s): | 300 mg/1 & nbsp; Allopurinol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Allopurinol
| Product NDC: | 57451-5026 |
| Labeler Name: | Ipca Laboratories Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090637 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110606 |
Package Information of Allopurinol
| Package NDC: | 57451-5026-2 |
| Package Description: | 1000 TABLET in 1 BOTTLE (57451-5026-2) |
NDC Information of Allopurinol
| NDC Code | 57451-5026-2 |
| Proprietary Name | Allopurinol |
| Package Description | 1000 TABLET in 1 BOTTLE (57451-5026-2) |
| Product NDC | 57451-5026 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Allopurinol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110606 |
| Marketing Category Name | ANDA |
| Labeler Name | Ipca Laboratories Limited |
| Substance Name | ALLOPURINOL |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] |
